Related references
Note: Only part of the references are listed.Octa-functional PLGA nanoparticles for targeted and efficient siRNA delivery to tumors
Jiangbing Zhou et al.
BIOMATERIALS (2012)
Biodegradable poly(amine-co-ester) terpolymers for targeted gene delivery
Jiangbing Zhou et al.
NATURE MATERIALS (2012)
Effects of Base Polymer Hydrophobicity and End-Group Modification on Polymeric Gene Delivery
Joel C. Sunshine et al.
BIOMACROMOLECULES (2011)
Targeted delivery of chlorotoxin-modified DNA-loaded nanoparticles to glioma via intravenous administration
Rongqin Huang et al.
BIOMATERIALS (2011)
A brain-targeted rabies virus glycoprotein-disulfide linked PEI nanocarrier for delivery of neurogenic microRNA
Do Won Hwang et al.
BIOMATERIALS (2011)
Therapeutic effect of neural stem cells expressing TRAIL and bortezomib in mice with glioma xenografts
Irina V. Balyasnikova et al.
CANCER LETTERS (2011)
A Developmental Taxonomy of Glioblastoma Defined and Maintained by MicroRNAs
Tae-Min Kim et al.
CANCER RESEARCH (2011)
Human Glioma Growth Is Controlled by MicroRNA-10b
Galina Gabriely et al.
CANCER RESEARCH (2011)
HIF Induces Human Embryonic Stem Cell Markers in Cancer Cells
Julie Mathieu et al.
CANCER RESEARCH (2011)
Reduced VEGF Production, Angiogenesis, and Vascular Regrowth Contribute to the Antitumor Properties of Dual mTORC1/mTORC2 Inhibitors
Beverly L. Falcon et al.
CANCER RESEARCH (2011)
Bortezomib Primes Glioblastoma, Including Glioblastoma Stem Cells, for TRAIL by Increasing tBid Stability and Mitochondrial Apoptosis
Thomas Unterkircher et al.
CLINICAL CANCER RESEARCH (2011)
Modulation of CCAAT/Enhancer Binding Protein Homologous Protein (CHOP)-dependent DR5 Expression by Nelfinavir Sensitizes Glioblastoma Multiforme Cells to Tumor Necrosis Factor-related Apoptosis-inducing Ligand (TRAIL)
Xiaobing Tian et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
Enzyme-synthesized poly(amine-co-esters) as nonviral vectors for gene delivery
Jie Liu et al.
JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A (2011)
Retrospective study of dasatinib for recurrent glioblastoma after bevacizumab failure
C. Lu-Emerson et al.
JOURNAL OF NEURO-ONCOLOGY (2011)
Phase I trial with biomarker studies of vatalanib (PTK787) in patients with newly diagnosed glioblastoma treated with enzyme inducing anti-epileptic drugs and standard radiation and temozolomide
Elizabeth R. Gerstner et al.
JOURNAL OF NEURO-ONCOLOGY (2011)
Lonafarnib (SCH66336) improves the activity of temozolomide and radiation for orthotopic malignant gliomas
Deviney Chaponis et al.
JOURNAL OF NEURO-ONCOLOGY (2011)
A Molecular Screening Approach to Identify and Characterize Inhibitors of Glioblastoma Stem Cells
Koppany Visnyei et al.
MOLECULAR CANCER THERAPEUTICS (2011)
Pathway Analysis of Glioblastoma Tissue after Preoperative Treatment with the EGFR Tyrosine Kinase Inhibitor Gefitinib-A Phase II Trial
Monika E. Hegi et al.
MOLECULAR CANCER THERAPEUTICS (2011)
Pathway inhibition: emerging molecular targets for treating glioblastoma
Wolfgang Wick et al.
NEURO-ONCOLOGY (2011)
Inhibition of PI3K/mTOR pathways in glioblastoma and implications for combination therapy with temozolomide
Gautam Prasad et al.
NEURO-ONCOLOGY (2011)
Colocalization of Gadolinium-Diethylene Triamine Pentaacetic Acid With High-Molecular-Weight Molecules After Intracerebral Convection-Enhanced Delivery in Humans
John H. Sampson et al.
NEUROSURGERY (2011)
Convection-enhanced delivery of camptothecin-loaded polymer nanoparticles for treatment of intracranial tumors
Andrew J. Sawyer et al.
DRUG DELIVERY AND TRANSLATIONAL RESEARCH (2011)
Surface modification of PLGA nanospheres with Gd-DTPA and Gd-DOTA for high-relaxivity MRI contrast agents
Gerda Ratzinger et al.
BIOMATERIALS (2010)
Pharmacology of capsaicin-, anandamide-, and N-arachidonoyl-dopamine-evoked cell death in a homogeneous transient receptor potential vanilloid subtype 1 receptor population
J. W. Davies et al.
BRITISH JOURNAL OF ANAESTHESIA (2010)
A phase I/II trial of GW572016 (lapatinib) in recurrent glioblastoma multiforme: clinical outcomes, pharmacokinetics and molecular correlation
Brian Thiessen et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2010)
Pharmacologic Inhibition of Cyclin-Dependent Kinases 4 and 6 Arrests the Growth of Glioblastoma Multiforme Intracranial Xenografts
Karine Michaud et al.
CANCER RESEARCH (2010)
EGFRvIII Antibody-Conjugated Iron Oxide Nanoparticles for Magnetic Resonance Imaging-Guided Convection-Enhanced Delivery and Targeted Therapy of Glioblastoma
Costas G. Hadjipanayis et al.
CANCER RESEARCH (2010)
An RNAi Screen Identifies TRRAP as a Regulator of Brain Tumor-Initiating Cell Differentiation
Heiko Wurdak et al.
CELL STEM CELL (2010)
Gene delivery by lipoplexes and polyplexes
Conchita Tros de Ilarduya et al.
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES (2010)
Efficient delivery of liposome-mediated MGMT-siRNA reinforces the cytotoxity of temozolomide in GBM-initiating cells
T. Kato et al.
GENE THERAPY (2010)
Tat-BMPs-PAMAM Conjugates Enhance Therapeutic Effect of Small Interference RNA on U251 Glioma Cells In Vitro and In Vivo
Lei Han et al.
HUMAN GENE THERAPY (2010)
Phase III Study of Enzastaurin Compared With Lomustine in the Treatment of Recurrent Intracranial Glioblastoma
Wolfgang Wick et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Targeted Nanoparticles Deliver siRNA to Melanoma
Yunching Chen et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2010)
A survey of glioblastoma genomic amplifications and deletions
Shailaja K. Rao et al.
JOURNAL OF NEURO-ONCOLOGY (2010)
Vorinostat enhances the cytotoxic effects of the topoisomerase I inhibitor SN38 in glioblastoma cell lines
Bhaswati Sarcar et al.
JOURNAL OF NEURO-ONCOLOGY (2010)
Phase 1 clinical trial of bortezomib in adults with recurrent malignant glioma
Surasak Phuphanich et al.
JOURNAL OF NEURO-ONCOLOGY (2010)
Poor drug distribution as a possible explanation for the results of the PRECISE trial Clinical article
John H. Sampson et al.
JOURNAL OF NEUROSURGERY (2010)
Radioisotopic Imaging of Neuroinflammation
Alexandra Winkeler et al.
JOURNAL OF NUCLEAR MEDICINE (2010)
A Chelator-Free Multifunctional [64Cu]CuS Nanoparticle Platform for Simultaneous Micro-PET/CT Imaging and Photothermal Ablation Therapy
Min Zhou et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2010)
The Novel Hsp90 Inhibitor NXD30001 Induces Tumor Regression in a Genetically Engineered Mouse Model of Glioblastoma Multiforme
Haihao Zhu et al.
MOLECULAR CANCER THERAPEUTICS (2010)
Sorafenib Induces Growth Arrest and Apoptosis of Human Glioblastoma Cells through the Dephosphorylation of Signal Transducers and Activators of Transcription 3
Fan Yang et al.
MOLECULAR CANCER THERAPEUTICS (2010)
Emetine Promotes von Hippel-Lindau-Independent Degradation of Hypoxia-Inducible Factor-2α in Clear Cell Renal Carcinoma
Hye-Sik Kong et al.
MOLECULAR PHARMACOLOGY (2010)
Safety and efficacy of erlotinib in first-relapse glioblastoma: a phase II open-label study
W. K. Alfred Yung et al.
NEURO-ONCOLOGY (2010)
Enzastaurin plus temozolomide with radiation therapy in glioblastoma multiforme: A phase I study
Nicholas Butowski et al.
NEURO-ONCOLOGY (2010)
Phase III randomized trial of CED of IL13-PE38QQR vs Gliadel wafers for recurrent glioblastoma
Fabio M. Iwamoto et al.
NEURO-ONCOLOGY (2010)
Canine spontaneous glioma: A translational model system for convection-enhanced delivery
Peter J. Dickinson et al.
NEURO-ONCOLOGY (2010)
Sorafenib exerts anti-glioma activity in vitro and in vivo
Markus D. Siegelin et al.
NEUROSCIENCE LETTERS (2010)
The many roles of microRNAs in brain tumor biology
Jay D. Turner et al.
NEUROSURGICAL FOCUS (2010)
Pattern of retinoblastoma pathway inactivation dictates response to CDK4/6 inhibition in GBM
W. Ruprecht Wiedemeyer et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
In Vivo SPECT and Real-Time Gamma Camera Imaging of Biodistribution and Pharmacokinetics of siRNA Delivery Using an Optimized Radiolabeling and Purification Procedure
Olivia M. Merkel et al.
BIOCONJUGATE CHEMISTRY (2009)
Convection-enhanced delivery of nanocarriers for the treatment of brain tumors
Emilie Allard et al.
BIOMATERIALS (2009)
Radiosensitisation of U87MG brain tumours by anti-epidermal growth factor receptor monoclonal antibodies
A. Diaz Miqueli et al.
BRITISH JOURNAL OF CANCER (2009)
Hypoxia-Inducible Factors Regulate Tumorigenic Capacity of Glioma Stem Cells
Zhizhong Li et al.
CANCER CELL (2009)
Autocrine TGF-β Signaling Maintains Tumorigenicity of Glioma-Initiating Cells through Sry-Related HMG-Box Factors
Hiroaki Ikushima et al.
CELL STEM CELL (2009)
PTEN/PI3K/Akt Pathway Regulates the Side Population Phenotype and ABCG2 Activity in Glioma Tumor Stem-like Cells
Anne-Marie Bleau et al.
CELL STEM CELL (2009)
Phase II Study of Neoadjuvant Imatinib in Glioblastoma: Evaluation of Clinical and Molecular Effects of the Treatment
Evangelia Razis et al.
CLINICAL CANCER RESEARCH (2009)
A Phase I Trial of Enzastaurin in Patients with Recurrent Gliomas
Teri N. Kreisl et al.
CLINICAL CANCER RESEARCH (2009)
Glioblastoma multiforme: a review of where we have been and where we are going
Cory Adamson et al.
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2009)
Phase II Trial of Vorinostat in Recurrent Glioblastoma Multiforme: A North Central Cancer Treatment Group Study
Evanthia Galanis et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
U-SPECT-II: An Ultra-High-Resolution Device for Molecular Small-Animal Imaging
Frans van der Have et al.
JOURNAL OF NUCLEAR MEDICINE (2009)
Dasatinib-induced autophagy is enhanced in combination with temozolomide in glioma
Vanessa Milano et al.
MOLECULAR CANCER THERAPEUTICS (2009)
Inhibition of Akt inhibits growth of glioblastoma and glioblastoma stem-like cells
Gary L. Gallia et al.
MOLECULAR CANCER THERAPEUTICS (2009)
Nanotechnology for Delivery of Drugs to the Brain for Epilepsy
Margaret F. Bennewitz et al.
NEUROTHERAPEUTICS (2009)
IDH1 and IDH2 Mutations in Gliomas
Hai Yan et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Uptake of ANG1005, A Novel Paclitaxel Derivative, Through the Blood-Brain Barrier into Brain and Experimental Brain Metastases of Breast Cancer
Fancy C. Thomas et al.
PHARMACEUTICAL RESEARCH (2009)
Pharmacokinetics and tumor dynamics of the nanoparticle IT-101 from PET imaging and tumor histological measurements
Thomas Schluep et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
The biosynthesis of N-arachidonoyl dopamine (NADA), a putative endocannabinoid and endovanilloid, via conjugation of arachidonic acid with dopamine
Sherry Shu-Jung Hu et al.
PROSTAGLANDINS LEUKOTRIENES AND ESSENTIAL FATTY ACIDS (2009)
Glioma-Derived Mutations in IDH1 Dominantly Inhibit IDH1 Catalytic Activity and Induce HIF-1α
Shimin Zhao et al.
SCIENCE (2009)
EGFR Signaling Through an Akt-SREBP-1-Dependent, Rapamycin-Resistant Pathway Sensitizes Glioblastomas to Antilipogenic Therapy
Deliang Guo et al.
SCIENCE SIGNALING (2009)
High resolution dynamic total-body animal imaging with U-SPECT-II
Brendan Vastenhouw et al.
JOURNAL OF NUCLEAR MEDICINE (2009)
Antitumour activity of ANG1005, a conjugate between paclitaxel and the new brain delivery vector Angiopep-2
A. Regina et al.
BRITISH JOURNAL OF PHARMACOLOGY (2008)
Aggravated endoplasmic reticulum stress as a basis for enhanced glioblastoma cell killing by bortezomib in combination with celecoxib or its non-coxib analogue, 2,5-dimethyl-celecoxib
Adel Kardosh et al.
CANCER RESEARCH (2008)
microRNA-7 inhibits the epidermal growth factor receptor and the Akt pathway and is down-regulated in glioblastoma
Benjamin Kefas et al.
CANCER RESEARCH (2008)
Deforolimus (AP23573) a novel mTOR inhibitor in clinical development
Monica Mita et al.
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2008)
Epidermal growth factor plays a crucial role in mitogenic regulation of human brain tumor stem cells
Akio Soeda et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
Identification and characterization of NVP-BEZ235, a new orally available dual phosphatidylinositol 3-kinase/mammalian target of rapamycin inhibitor with potent in vivo antitumor activity
Sauveur-Michel Maira et al.
MOLECULAR CANCER THERAPEUTICS (2008)
Phase II preradiation R115777 (tipifarnib) in newly diagnosed GBM with residual enhancing disease
Robert Lustig et al.
NEURO-ONCOLOGY (2008)
A small-animal imaging system capable of multipinhole circular/helical SPECT and parallel-hole SPECT
Jianguo Qian et al.
NUCLEAR INSTRUMENTS & METHODS IN PHYSICS RESEARCH SECTION A-ACCELERATORS SPECTROMETERS DETECTORS AND ASSOCIATED EQUIPMENT (2008)
PET versus SPECT: strengths, limitations and challenges
Arman Rahmim et al.
NUCLEAR MEDICINE COMMUNICATIONS (2008)
Preparation and initial characterization of biodegradable particles containing gadolinium-DTPA contrast agent for enhanced MRI
Amber L. Doiron et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
An integrated genomic analysis of human glioblastoma Multiforme
D. Williams Parsons et al.
SCIENCE (2008)
Antitumor activity of rapamycin in a phase I trial for patients with recurrent PTEN-Deficient glioblastoma
Tim F. Cloughesy et al.
PLOS MEDICINE (2008)
Glioblastoma-derived stem cell-enriched cultures form distinct subgroups according to molecular and phenotypic criteria
H. S. Guenther et al.
ONCOGENE (2008)
HIV-1 protease inhibitors nelfinavir and atazanavir induce malignant glioma death by triggering endoplasmic reticulum stress
Peter Pyrko et al.
CANCER RESEARCH (2007)
Dilation and degradation of the brain extracellular matrix enhances penetration of infused polymer nanoparticles
Keith B. Neeves et al.
BRAIN RESEARCH (2007)
Convection-enhanced delivery of nanoliposomal CPT-11 (irinotecan) and PEGylated liposomal doxorubicin (Doxil) in rodent intracranial brain tumor xenografts
Michal T. Krauze et al.
NEURO-ONCOLOGY (2007)
MicroRNA-21 knockdown disrupts glioma growth In vivo and displays synergistic cytotoxicity with neural precursor cell-delivered S-TRAIL in human gliomas
Maarten F. Corsten et al.
CANCER RESEARCH (2007)
Ribotoxic stress sensitizes glioblastoma cells to death receptor-induced apoptosis:: Requirements for c-Jun NH2-terminal kinase and Bim
Shuli Xia et al.
MOLECULAR CANCER RESEARCH (2007)
Phase I trial of tipifarnib (R115777) concurrent with radiotherapy in patients with glioblastoma multiforme
Elizabeth Cohen-Jonathan Moyal et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2007)
Glioma stem cells: Evidence and limitation
Xiaolong Fan et al.
SEMINARS IN CANCER BIOLOGY (2007)
CD133+ and CD133- glioblastoma-derived cancer stem cells show differential growth characteristics and molecular profiles
Dagmar Beier et al.
CANCER RESEARCH (2007)
Gefitinib in patients with progressive high-grade gliomas:: a multicentre phase II study by Gruppo Italiano Cooperativo di Neuro-Oncologia (GICNO)
E. Franceschi et al.
BRITISH JOURNAL OF CANCER (2007)
A perivascular niche for brain tumor stem cells
Christopher Calabrese et al.
CANCER CELL (2007)
Cyclopamine-mediated hedgehog pathway inhibition depletes stem-like cancer cells in glioblastoma
Eli E. Bar et al.
STEM CELLS (2007)
Convection-enhanced delivery of a topoisomerase I inhibitor (nanoliposomal topotecan) and a topoisomerase II inhibitor (pegylated liposomal doxorubicin) in intracranial brain tumor xenografts
Yoji Yamashita et al.
NEURO-ONCOLOGY (2007)
Interstitial transport and transvascular fluid exchange during infusion into brain and tumor tissue
Joshua H. Smith et al.
MICROVASCULAR RESEARCH (2007)
Paclitaxel: a review of adverse toxicities and novel delivery strategies
Neena I. Marupudi et al.
EXPERT OPINION ON DRUG SAFETY (2007)
Glioma stem cells promote radioresistance by preferential activation of the DNA damage response
Shideng Bao et al.
NATURE (2006)
Bone morphogenetic proteins inhibit the tumorigenic potential of human brain tumour-initiating cells
S. G. M. Piccirillo et al.
NATURE (2006)
Analysis of gene expression and chemoresistance of CDI33+ cancer stem cells in glioblastoma
Gentao Liu et al.
MOLECULAR CANCER (2006)
Mammalian target of rapamycin inhibition promotes response to epidermal growth factor receptor kinase inhibitors in PTEN-Deficient and PTEN-intact glioblastoma cells
Maria Y. Wang et al.
CANCER RESEARCH (2006)
Stem cell-like glioma cells promote tumor angiogenesis through vascular endothelial growth factor
Shideng Bao et al.
CANCER RESEARCH (2006)
Toxicity of cationic lipids and cationic polymers in gene delivery
Hongtao Lv et al.
JOURNAL OF CONTROLLED RELEASE (2006)
Notch pathway inhibition depletes stem-like cells and blocks engraftment in embryonal brain tumors
Xing Fan et al.
CANCER RESEARCH (2006)
Phase II trial of tipifarnib in patients with recurrent malignant glioma either receiving or not receiving enzyme-inducing antiepileptic drugs: A North American Brain Tumor Consortium study
Timothy F. Cloughesy et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
New treatment strategies for malignant gliomas
Sith Sathornsumetee et al.
EXPERT REVIEW OF ANTICANCER THERAPY (2006)
Tyrosine kinase inhibitors of vascular endothelial growth factor receptors in clinical trials: Current status and future directions
Alessandro Morabito et al.
ONCOLOGIST (2006)
Chemotherapy resistance of glioblastoma stem cells
A. Eramo et al.
CELL DEATH AND DIFFERENTIATION (2006)
Tissue affinity of the infusate affects the distribution volume during convection-enhanced delivery into rodent brains: Implications for local drug delivery
Ryuta Saito et al.
JOURNAL OF NEUROSCIENCE METHODS (2006)
18F-FET PET for planning of thermotherapy using magnetic nanoparticles in recurrent glioblastoma
Michail Plotkin et al.
INTERNATIONAL JOURNAL OF HYPERTHERMIA (2006)
AAV serotype 8-mediated gene delivery of a soluble VEGF receptor to the CNS for the treatment of glioblastoma
Thomas C. Harding et al.
MOLECULAR THERAPY (2006)
In vivo diffusion analysis with quantum dots and dextrans predicts the width of brain extracellular space
RG Thorne et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Phase 1 trial of gefitinib plus sirolimus in adults with recurrent malignant glioma
DA Reardon et al.
CLINICAL CANCER RESEARCH (2006)
Gadolinium-loaded liposomes allow for real-time magnetic resonance imaging of convection-enhanced delivery in the primate brain
R Saito et al.
EXPERIMENTAL NEUROLOGY (2005)
Real-time visualization and characterization of liposomal delivery into the monkey brain by magnetic resonance imaging
MT Krauze et al.
BRAIN RESEARCH PROTOCOLS (2005)
Gene therapy for malignant glioma: Current clinical status
KJ Pulkkanen et al.
MOLECULAR THERAPY (2005)
Imatinib and hydroxyurea in pretreated progressive glioblastoma multiforme: a patient series
G Dresemann
ANNALS OF ONCOLOGY (2005)
Extensive modulation of a set of microRNAs in primary glioblastoma
SA Ciafrè et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2005)
O-(2-[18F]fluoroethyl)-L-tyrosine PET for monitoring the effects of convection-enhanced delivery of paclitaxel in patients with recurrent glioblastoma
G Pöpperl et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2005)
Convection-enhanced drug delivery: Increased efficacy and magnetic resonance image monitoring
Y Mardor et al.
CANCER RESEARCH (2005)
MicroRNA-21 is an antiapoptotic factor in human glioblastoma cells
JA Chan et al.
CANCER RESEARCH (2005)
Identification of novel small molecule inhibitors of hypoxia-inducible factor-1 that differentially block hypoxia-inducible factor-1 activity and hypoxia-inducible factor-1α induction in response to hypoxic stress and growth factors
NM Chau et al.
CANCER RESEARCH (2005)
Convection enhanced delivery for the treatment of malignant gliomas: symposium review
MA Vogelbaum
JOURNAL OF NEURO-ONCOLOGY (2005)
Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma
R Stupp et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
O-(2-[18F]fluoroethyl)-L-tyrosine PET combined with MRI improves the diagnostic assessment of cerebral gliomas
D Pauleit et al.
BRAIN (2005)
Epidemiology and etiology of gliomas
H Ohgaki et al.
ACTA NEUROPATHOLOGICA (2005)
Distribution of liposomes into brain and rat brain tumor models by convection-enhanced delivery monitored with magnetic resonance imaging
R Saito et al.
CANCER RESEARCH (2004)
Convection-enhanced delivery of paclitaxel for the treatment of recurrent malignant glioma: a Phase I/II clinical study
Z Lidar et al.
JOURNAL OF NEUROSURGERY (2004)
Isolation and characterization of tumorigenic, stem-like neural precursors from human glioblastoma
R Galli et al.
CANCER RESEARCH (2004)
A distinct side population of cells with high drug efflux capacity in human tumor cells
C Hirschmann-Jax et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Isolation of cancer stem cells from adult glioblastoma multiforme
XP Yuan et al.
ONCOGENE (2004)
Identification of human brain tumour initiating cells
SK Singh et al.
NATURE (2004)
Suramin and radiotherapy in newly diagnosed glioblastoma: Phase 2 NABTT CNS Consortium study
JJ Laterra et al.
NEURO-ONCOLOGY (2004)
Histone deacetylase inhibitor, FK228, induces apoptosis and suppresses cell proliferation of human glioblastoma cells in vitro and in vivo
H Sawa et al.
ACTA NEUROPATHOLOGICA (2004)
In vitro cytotoxicity and in vivo distribution after direct delivery of PEG-camptothecin conjugates to the rat brain
AB Fleming et al.
BIOCONJUGATE CHEMISTRY (2004)
Brain uptake of thiamine-coated nanoparticles
PR Lockman et al.
JOURNAL OF CONTROLLED RELEASE (2003)
Imaging-guided convection-enhanced delivery and gene therapy of glioblastoma
J Voges et al.
ANNALS OF NEUROLOGY (2003)
N-oleoyldopamine, a novel endogenous capsaicin-like lipid that produces hyperalgesia
CJ Chu et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Direct evidence that polysorbate-80-coated poly( butylcyanoacrylate) nanoparticles deliver drugs to the CNS via specific mechanisms requiring prior binding of drug to the nanoparticles
J Kreuter et al.
PHARMACEUTICAL RESEARCH (2003)
In situ blood-brain barrier transport of nanoparticles
JM Koziara et al.
PHARMACEUTICAL RESEARCH (2003)
Clinical trials of adenoviruses in brain tumors: a review of Ad-p53 and oncolytic adenoviruses
GG Vecil et al.
JOURNAL OF NEURO-ONCOLOGY (2003)
Pharmacokinetics of the carmustine implant
AB Fleming et al.
CLINICAL PHARMACOKINETICS (2002)
Stem cells, cancer, and cancer stem cells
T Reya et al.
NATURE (2001)
Positron-emission tomography of vector-mediated gene expression in gene therapy for gliomas
A Jacobs et al.
LANCET (2001)
Toxicity, efficacy, and pharmacology of suramin in adults with recurrent high-grade gliomas
SA Grossman et al.
JOURNAL OF CLINICAL ONCOLOGY (2001)
(E)-5-(2-bromovinyl)-2′-deosyuridine potentiates ganciclovir-mediated cytotoxicity on herpes simplex virus-thymidine kinase-expressing cells
W Hamel et al.
CANCER GENE THERAPY (2001)
Control of the cell survival/death decision by cannabinoids
M Guzman et al.
JOURNAL OF MOLECULAR MEDICINE-JMM (2001)
A phase III clinical evaluation of herpes simplex virus type 1 thymidine kinase and ganciclovir gene therapy as an adjuvant to surgical resection and radiation in adults with previously untreated glioblastoma multiforme
NG Rainov
HUMAN GENE THERAPY (2000)
In vivo transchelation of copper-64 from TETA-octreotide to superoxide dismutase in rat liver
LA Bass et al.
BIOCONJUGATE CHEMISTRY (2000)
Anti-tumoral action of cannabinoids: Involvement of sustained ceramide accumulation and extracellular signal-regulated kinase activation
I Galve-Roperh et al.
NATURE MEDICINE (2000)
Share Paper
